Body Shortcuts


A global pioneer in the development of new drugs


SK Biopharmaceuticals seeks a healthier life for all stakeholders.

As a global pharmaceutical company responsible for the well-being of our planet,
we practice sustainable management to build trust with all stakeholders and make a bigger happiness.

Sustainability Focus Areas

  • Creating Healthcare Value
    Providing safe and reliable pharmaceuticals and adhering to the principles that must be followed in the research process is the starting point for creating healthcare value. Based on this, we strive to spread healthcare value so that more people can lead healthy lives.
    • Access to healthcare
    • Responsible R&D
    • Product safety and quality improvement
  • Sustainable
    We support the sustainability of partners in our value chain, from the development and manufacturing to the sale of innovative drugs, and contribute to expanding the ESG ecosystem.
    • Partners’ ESG management
  • Employee Competence and Satisfaction
    We make efforts to secure and nurture talents with specialized knowledge and creativity required in the development of innovative drugs, and create a satisfying working environment for our employees.
    • Human resource management
  • Transparent and
    Ethical Management
    As a pharmaceutical company dealing with human lives, we respect fundamental values and ensure trust and confidence from stakeholders by complying with various regulations required by authorities.
    • Business ethics and compliance
  • Minimizing Environmental Impacts
    We contribute to a sustainable and healthy life for future generations through climate change adaptation and systematic management of hazardous substances throughout our business activities.
    • Response to climate change
    • Hazardous substances and waste management

Sustainability Strategy

SK Biopharmaceuticals aims to achieve specific goals in five key areas.



Sustainability Strategy(Key Areas, Objectives)
Key Areas Objectives Achievement status
Creating Healthcare Value Create social value through new drugs
More than double the number of launch countries compared to 2020
Achieve zero product quality and safety related incidents
Sustainable Partnerships Obtain signatures from 100% of business partners regarding the Partners’ ESG Guidelines
Achieve 100% in major partners’ ESG risk assessment
Employee Competence and Satisfaction Strengthen recruitment and retention programs to secure talented individuals
Provide job expertise training programs for employees
Transparent and Ethical Management Attain 100% completion rate of anti-corruption and ethical training for employees
Enhance audit systems and compliance driven by the Board of Directors
Establish an anti-corruption and compliance system for subsidiaries and business partners
Minimizing Environmental Impacts Achieve Net-Zero in GHG emissions by 2040
Reduce the generation of hazardous substances by 1% annually until 2025

Sustainability Management System

SK Biopharmaceuticals maximizes the enterprise value by building
the E (Environmental), S (Social), and G (Governance) management
to improve its sustainability.

ESG/Strategic Committee under the Board of Directors makes decisions on ESG agendas to actively address risks and
opportunities of the environment, society, and governance.
In addition, the ESG Office under the CEO’s leadership composed of ESG-related staffs makes continuous efforts to
enhance the execution capabilities of ESG management.

SK Biopharmaceuticals Co., Ltd. Privacy Policy

SK Biopharmaceuticals Co., Ltd. (“Company”) is dedicated to complying with privacy regulations in pursuant of applicable laws and committed to protecting your privacy and personal information by setting a privacy policy in compliance with applicable laws. The Company may, in its discretion, amend this Privacy Policy according to changes in applicable laws and management.

1. Collection, Purpose, and Use of Personal Information

The Company collects only the minimum amount of personal information required to provide our services, and the collected personal information will only be used for the purposes stated in this policy. Your personal information is not used for any other purposes or disclosed to an outside source without prior authorization.

  • Purpose of collection : To review customer inquiries, contact customers to verify inquiry, reply, notify results.
  • Collected information : Required : email, name
  • Collected information : Optional : phone number, interests, nationality, company name, profession.
  • Method of collection : Collection through inquiries made through the website’s contact us section

2. Disclosure of Personal Information to Third Party

The Company uses the provided personal information only for the purposes stated in Article 1, and does not use your personal information or disclose such information to a third party without prior authorization. However, exceptions are provided if Company receives disclosure requests in accordance with procedures designated by the law. The following are examples of such exceptions.

  • Request that follows the procedure and method designated by provisions of the law
  • Request from investigative agencies that follow the procedure and method designated by the law for the purpose of investigation

3. Retention and Storage Period of Personal Information

The Company immediately destroys personal information a year after achieving the purpose of collection. However, if storage is necessary in accordance with applicable laws, the Company may store personal information for a period of time required by such law.

4. Destruction Procedure and Method of Personal Information

1. Destruction Procedure

  • In the event the Company no longer needs to maintain the personal information such as when the retention period has expired or the Company has achieved the information’s purpose, the Company shall immediately destroy such personal information.
  • In the event the Company is required by other laws to continually store the personal information despite the authorized retention period having expired or the purpose being achieved, the Company shall move such personal information to a separate database (DB) or change its storage location to store until the purpose of its continued retention has been achieved, upon which the Company shall immediately destroy the personal information.

2. Destruction Method

  • Personal information that is printed on paper shall be destroyed by being shredded or incinerated.
  • Personal information that is stored in electronic formats will be destroyed through technical methods in which records cannot be reproduced.

5. Rights and Duties of Information Provider and Exercising Methods

1. You may at any time make the following requests to exercise your privacy rights.

  • Request to access personal information
  • Request to revise information in case of error
  • Request to withdraw agreement/delete information
  • Request to cease operation

2. To exercise the rights stated in Article 5-1, you may state the request through a written statement, email, or fax, and the Company shall promptly execute the request upon receipt.

3. If the Company receives a request from the information provider to revise or delete personal information for any reason including error, the Company shall not use or provide personal information until the revision or deletion is completed.

4. You may exercise the rights stated in Article 5-1 through a delegated figure (“Agent”). However, in order for Agent to exercise the rights of information provider, Agent must submit a letter of attorney completed by the information provider.

5. The Company does not collect personal information from minors in principle. However, in the event that the collection of personal information from a minor is inevitable through 1:1 inquiry, the Company shall seek agreement from a legal representative and immediately destroy the information once the information’s purpose has been achieved or the authorized retention period has expired.

6. Measures to Secure Safety of Personal Information

The Company has established and is operating the following technical and managerial security measures to ensure that the collected personal information is not lost, stolen, leaked, falsified, or damaged.

1. Managerial Security Measures

  • The Company has established and is operating internal security plans in regards to privacy.

2. Technical Security Measures

  • Control of access to personal information and limited rights to access: The Company has installed security programs to prevent hackers or computer viruses from leaking and damaging personal information and is conducting regular updates and maintenance.
  • The Company has appointed the minimum number of representatives that have access to personal information and conducts regular internal training sessions. The training of such representatives is held on a strictly confidential basis and the Company prescribes clear responsibilities in accidents regarding personal information to all current and former employees.

7. Contacts of Personal Information Manager and Representative

To protect the personal information provided to us and handle complaints and inquiries from information providers regarding their personal information, the Company has designated the following department and representative in charge of protecting personal information.

  • Personal Information Representative and Department : Wan-ho Nam, SK Biopharmaceuticals Business Strategy Team, Business Management Manager
  • Phone : +82-31-8093-0114
  • Email :

8. Amendment and Notice of Privacy Policy

1. This Privacy Policy takes effect starting July 1, 2018.

2. In the event of any future addition, deletion, revision, and such amendments to the privacy policy following changes in applicable laws or security technology, the Company will notify the purpose and contents of the amendment on the Company’s website at least a week prior to enacting the amended privacy policy.

Date of notice and enactment: July 1, 2018